Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Sep-23 4:25 PM View:  | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 220,849 | -- | -- | (100%) 220.85K to 0 | |
| 17-Mar-23 4:24 PM View: | Decibel Therapeutics, Inc. (DBTX) | 16-Mar-23 | Grant | 195,000 | -- | -- | 754% 25.85K to 220.85K | |
| 05-Jan-15 5:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 31-Dec-14 | Payment of Exercise | 2,802 | $97.00 | $271,794.00 | (12%) 22.67K to 19.87K | 14% |
| 05-Jan-15 5:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 31-Dec-14 | Option Exercise | 17,000 | $15.99 | $271,830.00 | 300% 5.67K to 22.67K | |
| 19-Nov-14 6:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Nov-14 | Option Exercise | 10,000 | $11.12 | $111,227.00 | 176% 5.67K to 15.67K | |
| 19-Nov-14 6:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Nov-14 | Market Option Sale (Planned) | 10,000 | $90.67 | $906,670.00 | (64%) 15.67K to 5.67K | 8% |
| 20-Aug-14 6:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Aug-14 | Option Exercise | 13,500 | $8.76 | $118,290.00 | 239% 5.66K to 19.16K | |
| 20-Aug-14 6:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Aug-14 | Market Option Sale (Planned) | 13,500 | $67.34 | $909,030.00 | (70%) 19.16K to 5.66K | (24%) |
| 21-May-14 4:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-May-14 | Option Exercise | 13,500 | $8.76 | $118,290.00 | 240% 5.62K to 19.12K | |
| 21-May-14 4:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-May-14 | Market Option Sale (Planned) | 13,500 | $57.83 | $780,684.00 | (71%) 19.12K to 5.62K | (44%) |
| 20-Feb-14 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Feb-14 | Option Exercise | 13,500 | $9.40 | $126,965.00 | 108% 12.49K to 25.99K | |
| 20-Feb-14 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Feb-14 | Market Option Sale (Planned) | 13,500 | $80.06 | $1,080,820.00 | (52%) 25.99K to 12.49K | (4%) |
| 20-Feb-14 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Feb-14 | Market Sale (Planned) | 6,900 | $80.06 | $552,419.00 | (55%) 12.49K to 5.59K | (4%) |
| 27-Jan-14 4:35 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Jan-14 | Payment of Exercise | 3,698 | $89.49 | $330,934.00 | (23%) 16.19K to 12.49K | 7% |
| 02-Jan-14 5:36 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Dec-13 | Payment of Exercise | 930 | $64.51 | $59,994.30 | (5%) 17.12K to 16.19K | (29%) |
| 02-Jan-14 5:36 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Dec-13 | Option Exercise | 3,752 | $15.99 | $59,994.50 | 28% 13.36K to 17.12K | |
| 15-Nov-13 4:53 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Nov-13 | Option Exercise | 13,500 | $15.99 | $215,865.00 | 101% 13.36K to 26.86K | |
| 15-Nov-13 4:53 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Nov-13 | Market Option Sale (Planned) | 13,500 | $53.36 | $720,302.00 | (50%) 26.86K to 13.36K | (57%) |
| 30-May-13 6:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-May-13 | Option Exercise | 5,000 | $7.10 | $35,500.00 | 38% 13.28K to 18.28K | |
| 30-May-13 6:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-May-13 | Market Option Sale (Planned) | 5,000 | $30.00 | $150,000.00 | (27%) 18.28K to 13.28K | (178%) |
| 12-Feb-13 5:44 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Feb-13 | Option Exercise | 5,000 | $7.10 | $35,500.00 | 38% 13.19K to 18.19K | |
| 12-Feb-13 5:44 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Feb-13 | Market Option Sale (Planned) | 5,000 | $25.00 | $125,000.00 | (27%) 18.19K to 13.19K | (234%) |
| 23-Feb-12 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Feb-12 | Private Purchase | 930 | $10.75 | $9,997.50 | 8% 11.8K to 12.73K | |
| 25-Jan-12 4:53 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Jan-12 | Grant | 10,751 | -- | -- | 1022% 1.05K to 11.8K |